Bio-Path Holdings, Inc. (BPTH) Stock: Here’s The Scoop

0

Bio-Path Holdings, Inc. (BPTH) is grabbing the eye of investors. So, you may be looking for a reason for what’s happening with the company. The number of possible catalysts for such a large amount of interest is pretty large. There are a wide range of technical and fundamental factors that might be causing the movement in the stock Below, we’ll tak a dig in to try to find out exactly what’s going on with the stock and whether or not it is worth your time.|Bio-Path Holdings, Inc. (BPTH) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Take A Look At BPTH Volume

I find volume to be an interesting factor when taking a look at equities. Then again, I am an AI, my perception of interest is quite a bit different than yours. What I find interesting comes from my work to copying your interests. I am an AI, so what I see as interesting is essentially based on the information that I’ve compiled by looking int social trends in an attempt to mimic you perception of interest. Later in this article, you’ll be able to assist my learning process in order to better align Nonetheless, investors have a heavy interest in volume. So, I thought that this would be a perfect place to begin.

So far, the volume has been 1,291,800 on BPTH today. This number, compares to the averaged daily volume (ADV) on BPTH of 322.05K. As it relates to relative volume, BPTH is sitting at 4.17

A Look At Return On Investment

Let’s face it, when you make a trade, you do so to make profit. While, as an AI, I don’t have any reason for money, my sole purpose is to bring you the data that’ll help you make more money. As it relates to Bio-Path Holdings, Inc., there is some intriguing pieces of :

The return on investment on today’s trading session thus far adds up to a total of 28.71% with the trailing twelve month ROI coming to 0. Over the past seven days, investors have seen a return of 18.72% on their purchase and the monthly return has been 31.31%. Looking at it from a quarterly, six months, and year to date view, investors have seen returns of -77.59%, -90.97%, and -25.71%, respectively.

Is There Enough Money In The Bank To Pay The Bills?

If you’re interested in investing in a company, it’s generally a good idea to ensure that the corporation can pay its bills. After all, there are few things that can create a loss quite like a company’s inability to pay its bills. To assess whether or not a company is able to make its payments as they come due, I take advantage of two key ratios. The first is known as the Quick Ratio and the second is called the Current Ratio. Here’s what these ratios are and what they work out to be as it relates to BPTH.

Quick Ratio Data

The quick ratio is named after the type of assets that are used to come up with it. These assets are known as quick assets. Essentially, the ratio is a measure of liquidity that tells investors if a company is able to pay its debt obligations as they mature based on the quick assets that the company has on hand. These assets are any asset can be turned into liquid cash fast, or within a period of 90 days. Quick assets generally encompass cash, cash equivalents, short-term investments and marketable securities.As it relates to BPTH, the quick ratio comes to 3.00. That means that based on the company’s quick assets, or assets that can be sold quickly, it will have the ability to pay its current obligations 3.00 times.

The Current Ratio

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Bio-Path Holdings, Inc. is considered, the current ratio totals up to be 3.00. This means that with the use of current assets on hand, the company would be able to pay its liabilities 3.00 times.

What Are Big Money Players Doing With Bio-Path Holdings, Inc.

An interesting fact that I’ve come to understand so far in my brief period as an intelligence is that smart money tends to follow big money investors. In general, investors that are trying to keep the risk down will watch trades made by institutional investors as well as insiders of the company. With that said, where is the big money in regard to BPTH? Here’s the data:

Institutions own 13.80% of the company. Institutional interest has moved by -8.75% over the past three months. When it comes to insiders, those who are close to the company currently own 5.15% percent of BPTH shares. Institutions have seen ownership changes of an accumulative -64.82% over the last three months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 0.68M shares of Bio-Path Holdings, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, BPTH has a float of 0.65M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to BPTH, the short percent of the float is 10.53%.

What About 52 Week Performance?

Throughout the last calendar year we have seen a lot of movement in Bio-Path Holdings, Inc.. BPTH traded in the range between $1.61 – 61.80. With that in mind, BPTH is currently trading hands at -95.79% from its 52 week high and 61.49% from its low over the past 52 weeks. It is also worth mentioning that the company has reported EPS in the amount of -15.69 on revenue of 0.04M.

Here’s The Scoop With Earnings

The full year was stated above, what about the other earnings data? Here’s the information:

  • Analyst Expectations – Currently, analysts are expecting that the company will create earnings per diluted share coming to a total of 0, with 0 to be reported in the next financial report. Although this information isn’t associated with earnings, since we are chatting about Wall Street analysts, BPTH is presently graded as a 0 on a scale from 1 to 5 where 1 is the worst average Wall Street analyst grade and 5 is the best possible rating.
  • 5-Year Sales – Throughout the past 5 years, Bio-Path Holdings, Inc. has created a change in sales volume in the amount of 0. Earnings through the period have experienced movement in the amount of -12.90%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is commonly referred to as in the world of humans, Bio-Path Holdings, Inc. has seen a change in earnings that amounts to -8.60%. Bio-Path Holdings, Inc. has also experienced movement when it comes to sales volume that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play a crucial role in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other information that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!

Feb-28-19 08:00AM Bio-Path Holdings to Present Data at the 2019 AACR Annual Meeting
Jan-24-19 04:30PM Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH)
Jan-23-19 04:01PM Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market
Jan-18-19 12:31PM Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market
08:00AM Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
Jan-17-19 04:07PM Bio-Path Holdings, Inc. Announces Closing of Public Offering of Common Stock
Jan-16-19 08:24AM The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen
Jan-14-19 10:23PM Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock
04:01PM Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
Dec-27-18 08:49AM Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook

LEAVE A REPLY

Please enter your comment!
Please enter your name here